One of the key learning outcomes of university education in general, and liberal arts programmes,  in particular, is that ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X “Everyone that has ever told me that I’m not good enough or I can’t or the voices in my head that ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

If you purchase a product through a link on our site, we may receive compensation. Here’s a look at the remainder of this season of “The Challenge,” courtesy of ...

TikTok has long been seen as a breeding ground for dumb stunts, but some challenges are truly hazardous to one’s health. A recent survey found that the blackout challenge is the deadliest of all — ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...